283 related articles for article (PubMed ID: 30846095)
1. The Interleukin-1 Axis and Risk of Death in Patients With Acutely Decompensated Heart Failure.
Pascual-Figal DA; Bayes-Genis A; Asensio-Lopez MC; Hernández-Vicente A; Garrido-Bravo I; Pastor-Perez F; Díez J; Ibáñez B; Lax A
J Am Coll Cardiol; 2019 Mar; 73(9):1016-1025. PubMed ID: 30846095
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of soluble concentrations of interleukin family member ST2 as predictor of mortality in patients with acutely decompensated heart failure relative to left ventricular ejection fraction.
Manzano-Fernández S; Mueller T; Pascual-Figal D; Truong QA; Januzzi JL
Am J Cardiol; 2011 Jan; 107(2):259-67. PubMed ID: 21211603
[TBL] [Abstract][Full Text] [Related]
3. Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure.
Pascual-Figal DA; Manzano-Fernández S; Boronat M; Casas T; Garrido IP; Bonaque JC; Pastor-Perez F; Valdés M; Januzzi JL
Eur J Heart Fail; 2011 Jul; 13(7):718-25. PubMed ID: 21551163
[TBL] [Abstract][Full Text] [Related]
4. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of sST2 and NT-proBNP at admission in heart failure with preserved, mid-ranged and reduced ejection fraction.
Huang A; Qi X; Hou W; Qi Y; Zhao N; Liu K
Acta Cardiol; 2018 Feb; 73(1):41-48. PubMed ID: 28944719
[TBL] [Abstract][Full Text] [Related]
6. Serial monitoring of soluble interleukin family member ST2 in patients with acutely decompensated heart failure.
Manzano-Fernández S; Januzzi JL; Pastor-Pérez FJ; Bonaque-González JC; Boronat-Garcia M; Pascual-Figal DA; Montalban-Larrea S; Navarro-Peñalver M; Andreu-Cayuelas JM; Valdés M
Cardiology; 2012; 122(3):158-66. PubMed ID: 22832599
[TBL] [Abstract][Full Text] [Related]
7. ST2 elevation in heart failure, predictive of a high early mortality.
Dalal JJ; Digrajkar A; Das B; Bansal M; Toomu A; Maisel AS
Indian Heart J; 2018; 70(6):822-827. PubMed ID: 30580851
[TBL] [Abstract][Full Text] [Related]
8. Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the Multinational Observational Cohort on Acute Heart Failure (MOCA) study.
Lassus J; Gayat E; Mueller C; Peacock WF; Spinar J; Harjola VP; van Kimmenade R; Pathak A; Mueller T; Disomma S; Metra M; Pascual-Figal D; Laribi S; Logeart D; Nouira S; Sato N; Potocki M; Parenica J; Collet C; Cohen-Solal A; Januzzi JL; Mebazaa A;
Int J Cardiol; 2013 Oct; 168(3):2186-94. PubMed ID: 23538053
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of soluble ST2 biomarker in heart failure patients with reduced ejection fraction - A multicenter study.
Bahuleyan CG; Alummoottil GK; Abdullakutty J; Lordson AJ; Babu S; Krishnakumar VV; Pillai AM; Abraham G; Dilip MN
Indian Heart J; 2018 Jul; 70 Suppl 1(Suppl 1):S79-S84. PubMed ID: 30122243
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic value of combining serum soluble ST2 and interleukin-33 for heart failure patients with preserved left ventricular ejection fraction].
Luo NS; Zhang HF; Liu PM; Lin YQ; Huang TC; Yang Y; Wang JF
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Mar; 45(3):198-203. PubMed ID: 28316175
[No Abstract] [Full Text] [Related]
11. Elevated soluble ST2 and depression increased the risk of all-cause mortality and hospitalization in patients with heart failure.
Xu SD; Su GH; Lu YX; Shuai XX; Tao XF; Meng YD; Luo P
Int Heart J; 2014; 55(5):445-50. PubMed ID: 25070116
[TBL] [Abstract][Full Text] [Related]
12. The Effectiveness of Outpatient Treatment Under the Control of the Soluble ST2 Receptor Concentration in Patients With Heart Failure With Reduced Ejection Fraction After Acute Decompensation of Heart Failure.
Muksinova MD; Narusov OY; Sychev AV; Sharf TV; Masenko VP; Tereshchenko SN; Skvortsov AA
Kardiologiia; 2023 Dec; 63(12):87-92. PubMed ID: 38156496
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure.
Tang WH; Wu Y; Grodin JL; Hsu AP; Hernandez AF; Butler J; Metra M; Voors AA; Felker GM; Troughton RW; Mills RM; McMurray JJ; Armstrong PW; O'Connor CM; Starling RC
JACC Heart Fail; 2016 Jan; 4(1):68-77. PubMed ID: 26656144
[TBL] [Abstract][Full Text] [Related]
14. Soluble ST2 and brain natriuretic peptide predict different mode of death in patients with heart failure and preserved ejection fraction.
Sugano A; Seo Y; Ishizu T; Sai S; Yamamoto M; Hamada-Harimura Y; Machino-Ohtsuka T; Obara K; Nishi I; Aonuma K; Nogami A
J Cardiol; 2019 Apr; 73(4):326-332. PubMed ID: 30580891
[TBL] [Abstract][Full Text] [Related]
15. BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study.
Khalid U; Wruck LM; Quibrera PM; Bozkurt B; Nambi V; Virani SS; Jneid H; Agarwal S; Chang PP; Loehr L; Basra SS; Rosamond W; Ballantyne CM; Deswal A
Int J Cardiol; 2017 Apr; 233():61-66. PubMed ID: 28185703
[TBL] [Abstract][Full Text] [Related]
16. The utilization and prognostic impact of B-type Natriuretic Peptide in hospitalized acute decompensated heart failure in an Asian population.
Chen LJ; Hung CL; Yeh HI; Jeng MJ; Su CH; Wu TY; Shih SC; Tsai CH
BMC Cardiovasc Disord; 2016 Sep; 16(1):178. PubMed ID: 27613439
[TBL] [Abstract][Full Text] [Related]
17. The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study.
Markousis-Mavrogenis G; Tromp J; Ouwerkerk W; Devalaraja M; Anker SD; Cleland JG; Dickstein K; Filippatos GS; van der Harst P; Lang CC; Metra M; Ng LL; Ponikowski P; Samani NJ; Zannad F; Zwinderman AH; Hillege HL; van Veldhuisen DJ; Kakkar R; Voors AA; van der Meer P
Eur J Heart Fail; 2019 Aug; 21(8):965-973. PubMed ID: 31087601
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea.
Shah RV; Chen-Tournoux AA; Picard MH; van Kimmenade RR; Januzzi JL
Circ Heart Fail; 2009 Jul; 2(4):311-9. PubMed ID: 19808354
[TBL] [Abstract][Full Text] [Related]
19. Recurrent Acute Decompensated Heart Failure Admissions for Patients With Reduced Versus Preserved Ejection Fraction (from the Atherosclerosis Risk in Communities Study).
Caughey MC; Sueta CA; Stearns SC; Shah AM; Rosamond WD; Chang PP
Am J Cardiol; 2018 Jul; 122(1):108-114. PubMed ID: 29703442
[TBL] [Abstract][Full Text] [Related]
20. [Soluble Suppression of Tumorogenicity 2 Increases Opportunities for Risk Stratification After Acute Heart Failure Decompensation].
Skvortsov AA; Protasov VN; Narusov OY; Koshkina DE; Nasonova SN; Masenko VP; Tereschenko SN
Kardiologiia; 2017 Jan; (1):48-58. PubMed ID: 28290833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
